Work

23andMe’s bankruptcy raises concerns about privacy in the era of big data

Year: 2025
Type: editorial
Abstract: On 23 March 2025, the direct-to-consumer genetic testing company 23andMe filed a voluntary Chapter 11 petition in a US bankruptcy court. 1 The objective of this bankruptcy is to sell the company quickly, as is common through Chapter 11.But 23andMe has a distinctive feature: the company holds a genetic dataset drawn from over 15 million customers.2 3 The sale of 23andMe through bankruptcy thus raises extensive privacy and discrimination issues that are not comprehensively addressed under US laws.Current US federal laws would need to be updated or a comprehensive privacy law enacted to give all Americans adequate control over their data, including full protection from discrimination based on their genetic profile.The stakes are particularly high given the range of information 23andMe holds.The company has collected genetic information, registration information (such as name, address, and credit card information), sample information (including saliva samples and laboratory values), self-reported information (such as health-related information, family history, and ethnicity), biometric information to verify customers' identity, user content including messages sent via 23andMe's services, and web-behaviour information.4 Some information could reveal things about family members who never consented.Bankruptcy offers a mechanism to sell this personal information free and clear of allegations of previous mishandling.
Source: BMJ
Language: English
Subfield: Law
Open Access status: bronze
OpenAlex ID: W4410775499
Cites: 1
Cited by: 10
Related to: 10